Paul Tudor Jones Moderna, Inc. Call Options Transaction History

Tudor Investment Corp Et Al

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$63.64 - $125.14 $11.6 Million - $22.9 Million	183,000 Added 144.44%	309,700 $20.7 Million
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $5.7 Million - $9.38 Million	56,300 Added 79.97%	126,700 $15 Million
Q1 2024 May 15, 2024	BUY	$85.37 - $115.44 $1.73 Million - $2.34 Million	20,300 Added 40.52%	70,400 $7.5 Million
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $2.84 Million - $4.26 Million	40,800 Added 438.71%	50,100 $4.98 Million
Q3 2023 Nov 15, 2023	BUY	$96.41 - $126.61 $896,613 - $1.18 Million	9,300 New	9,300 $960,000

953

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.5B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.